A Phase 1b/2 Study of Alvocidib Plus Decitabine or Azacitidine in Patients With MDS

Clinical trial NCT03593915 · TERMINATED

Trial details

NCT number: NCT03593915
Sponsor: Sumitomo Pharma America, Inc.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes (MDS)

Start date: 2018-08-29
Primary completion: 2021-08-16
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.